In Australia, Atrial Fibrillation is a more common cause of hospital admissions than heart attacks.
The need for more research into preventing and managing this cardiovascular condition is vital, with Atrial Fibrillation putting people at higher risk of stroke, heart failure, kidney disease, dementia and premature death.
Together with our Group charity Australian Heart Research, we are funding medical research focused on the prevention, early detection, management and treatment of Atrial Fibrillation.
Professor Jeroen Hendriks explains "What is Atrial Fibrillation?"
Atrial Fibrillation Support
Undertaking a clinical trial of a drug which shows promise in preventing Atrial Fibrillation by addressing its three common risk factors: high blood pressure, excess weight and diabetes.
Investigating whether an aggressive approach to weight and lifestyle management can decrease Atrial Fibrillation (AD) symptoms and reduce hospitalisations.
Running a specialised and multi-disciplinary clinic at the Royal Adelaide Hospital that has an integrated care (i-CARE) approach for managing people’s Atrial Fibrillation, ensuring strong collaboration between specialists, nurses and allied professionals.
Undertaking overnight sleep studies and analysing other sleep data to determine whether the electrophysiological changes experienced by people with sleep apnoea contributes to Atrial Fibrillation (AF).
Investigating whether subclinical Atrial Fibrillation is associated with risks of dementia and whether the screening guidelines for Atrial Fibrillaton need to be adapted.